您当前的位置：
首页 >
文章列表页 >
Posaconazole for prevention of invasive fungal infections： a rapid health technology assessment
更新时间：2026-05-26

    • Posaconazole for prevention of invasive fungal infections： a rapid health technology assessment

    • ZHONGGUO YAOFANG   Vol. 37, Issue 10, Pages: 1364-1369(2026)

    • DOI：10.6039/j.issn.1001-0408.2026.10.22    

      CLC： R978.5

    • Received：25 December 2025，

      Revised：2026-05-07，

      Accepted：08 May 2026，

      Published：30 May 2026

    移动端阅览

  • LI Yujie,MA Jiantong,HUANG Gerile,et al.Posaconazole for prevention of invasive fungal infections： a rapid health technology assessment[J].ZHONGGUO YAOFANG,2026,37(10):1364-1369. DOI： 10.6039/j.issn.1001-0408.2026.10.22.

  •  
  •  

0

Views

13

下载量

0

CSCD

Alert me when the article has been cited
提交
Tools
Download
Export Citation
Share
Add to favorites
Add to my album

Related Articles

Rapid health technology assessment of deucravacitinib in the treatment of moderate-to-severe plaque psoriasis
Efficacy and safety of letermovir in preventing cytomegalovirus infection after allogeneic hematopoietic stem cell transplantation
Denosumab in the Treatment of Giant Cell Tumor of Bone ：A Health Technology Assessment
棘白菌素类抗真菌药物预防侵袭性念珠菌血症有效性与安全性
Comparison of efficacy and safety between tildrakizumab and secukinumab in the treatment of moderate-to-severe plaque psoriasis

Related Author

GAO Xing
KONG Shujing
LIU Tianya
QIU Xinran
HAN Jia
LI Shuyue
LIANG Ranran
SONG Xianmin

Related Institution

Dept. of Pharmacy， the Affiliated Hospital of Xuzhou Medical University
Dept. of Dermatology， the Affiliated Hospital of Xuzhou Medical University
Dept. of Anesthesiology， the Affiliated Hospital of Xuzhou Medical University
Dept. of Clinical Pharmacy， Xinhua Hospital Affiliated to Shanghai Jiao Tong University School of Medicine
Dept. of Pharmacy， Shanxi Cancer Hospital/Shanxi Hospital of Chinese Academy of Medical Sciences Cancer Hospital
0